DataMEDS AI, Inc. MEDS
0.73 USD -0.01 (-1.53%)
Regular-session close
1.13 +0.40 +55.28%
After hours · Nov 19, 7:59 PM ET
0.7082 Day range 0.8398
0.64 52-week range 31.60
- YTD
- -96.36%
- 1 year
- -97.49%
5D -0.1323 (-15.38%)
- Market cap
- 4.17M
- Revenue (ttm)
- 7.45M
- Profit margin
- 56.68%
- EPS (ttm)
- -18.02
- Shares out
- 1.75M
- Forward P/E
- -16.87
- YTD return
- -96.36%
- 1-year return
- -97.49%
- Volume
- 15.03M
- Avg volume
- 6.69M
- Open
- 0.7351
- Previous close
- 0.739
- Day's range
- 0.7082 – 0.8398
- 52-week range
- 0.64 – 31.60
- Analysts
- Buy
- 50-day average
- 7.54
Key statistics
- 200-day average
- 9.04
- Enterprise value
- 3.24M
- Price / sales
- 1.78
- Price / book
- 0.91
- Revenue growth
- -94.90%
- Total cash
- 7.72M
- Total debt
- 193.60K
- Short % of float
- 1.13%
Fundamental scorecard
3 of 25 checks passed on MEDS’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 2 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
MEDS Revenue — quarterly 2.67M
MEDS Net income — quarterly 10.59M
MEDS EPS — quarterly 3.29
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 9, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jun 26, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Jan 16, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | -0.30 | — | — | — |
| Mar 27, 2023 | Dec 1, 2022 | -0.90 | — | — | — |
About DataMEDS AI, Inc.
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- trxadehealth.com
News
DataMeds AI Agrees To Acquire Certain Assets From Estate Of Todos Medical, Terms Undisclosed
12 Health Care Stocks Moving In Wednesday's Intraday Session
FDA Flags Potential Vision Loss Risk With GLP-1 Drugs, Requiring Weight-Loss Medicines Like Wegovy and Zepbound to Carry New Warning DataMeds AI's Corexa Pharmacy Unit Completes First Commercial Sale Of One Of Six FDA-Recommended Peptides
Datavault AI Fires CEO Nathaniel Bradley DataMeds AI Signs MoU With Florida HMO To Deploy The Health Lives Here Mobile App For GLP-1 Management
DataMeds AI Terminates Second Amended LOI With Datavault AI And Partners Due To Market Conditions; No Shares To Be Issued Under LOI, Existing REBOOT And Datavault Agreements Remain In Effect; Co Does Not Owe Any Fees Or Obligation As A Result Of The Termination
DataMEDS AI Moves Into Growing Peptide Market DataMeds AI's Pharmacy Unit Corexa Health Enters Agreement For Commercial Supply Of Six Peptides Recommended By The FDA Pharmacy Compounding Advisory Committee; Intends To Start Distributing Prescriptions In November 2026
DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network
Your note
Sign in to keep a note on MEDS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AJJARAPU SURENDRA K | Chief Executive Officer | Stock Award(Grant) | Jan 4, 2024 | 0 |
| DOSS HOWARD A | Chief Financial Officer | Stock Award(Grant) | Apr 13, 2020 | 12,500 |
| FELL DONALD G. | Director | Stock Award(Grant) | Aug 31, 2022 | 75,664 |
| HUFFMAN JANET | Chief Financial Officer | Stock Award(Grant) | Dec 12, 2022 | 71,551 |
| JENNINGS CHRISTINE L. | Director | Stock Award(Grant) | May 26, 2021 | 10,912 |
| NEWELL A. JEFFREY | Director | Stock Award(Grant) | Dec 29, 2022 | 79,062 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Morgan Stanley | 1.11% | 13,867 | 180.96K | Jun 29, 2023 |
| Barclays Plc | 0.38% | 4,801 | 62.65K | Jun 29, 2023 |
| Tower Research Capital LLC (TRC) | 0.17% | 2,135 | 27.86K | Jun 29, 2023 |
| JP Morgan Chase & Company | 0.07% | 884 | 11.54K | Jun 29, 2023 |
| UBS Group AG | 0.07% | 900 | 11.74K | Jun 29, 2023 |
| Ronald Blue Trust, Inc. | 0.03% | 357 | 2.51K | Sep 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 1.94% | 24,189 | 101.59K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 1.23% | 15,392 | 64.65K | May 30, 2023 |
| Vanguard Extended Market Index Fund | 0.21% | 2,643 | 34.49K | Jun 29, 2023 |
| Fidelity Series Total Market Index Fund | 0.15% | 1,931 | 8.11K | May 30, 2023 |
